P-A drug identification program
Association will ask FDA to require marking or imprinting of each OTC drug tablet, capsule, lozenge or oral dose form with identity of medication. In the meantime, P-A has announced a voluntary industry effort. Program will help to promote added consumer awareness and aid in identification of drugs in over-dose cases, P-A says. A similar mandatory program is before the Washington state legislature. P-A is asking the state to defer the plan until a nationwide program is put into effect.
You may also be interested in...
Investors in surgical robotics company Auris say Johnson & Johnson failed to support the company per their merger agreement.
based firm, which markets Activa hand sanitizers, is offering Self+ immunity supplements in Brain, Energy and Unwind formulations in powder format for mixing with water.